To access the full text documents, please follow this link: http://hdl.handle.net/2445/107753
dc.contributor | Universitat de Barcelona |
---|---|
dc.contributor.author | Darbà, Josep |
dc.contributor.author | Ramírez, Gabriela |
dc.contributor.author | García-Rivero, Juan L. |
dc.contributor.author | Mayoralas, Sagrario |
dc.contributor.author | Pascual, José Francisco |
dc.contributor.author | Roger, Albert |
dc.contributor.author | Vargas, Diego |
dc.contributor.author | Bijedic, Adi |
dc.date | 2017-03-02T15:37:24Z |
dc.date | 2017-03-02T15:37:24Z |
dc.date | 2016-09 |
dc.date | 2017-03-02T15:37:24Z |
dc.identifier.citation | 1178-6981 |
dc.identifier.citation | 668397 |
dc.identifier.uri | http://hdl.handle.net/2445/107753 |
dc.format | 10 p. |
dc.format | application/pdf |
dc.language.iso | eng |
dc.publisher | Dove Medical Press |
dc.relation | Reproducció del document publicat a: https://doi.org/10.2147/CEOR.S111453 |
dc.relation | Clinicoeconomics and Outcomes Research, 2016, vol. 8 , p. 435-444 |
dc.relation | https://doi.org/10.2147/CEOR.S111453 |
dc.rights | cc-by-nc (c) Darbà, Josep et al., 2016 |
dc.rights | info:eu-repo/semantics/openAccess |
dc.rights | http://creativecommons.org/licenses/by-nc/3.0/es |
dc.subject | Administració de medicaments |
dc.subject | Asma |
dc.subject | Malalties pulmonars obstructives cròniques |
dc.subject | Tractament tèrmic |
dc.subject | Economia de la salut |
dc.subject | Administration of drugs |
dc.subject | Asthma |
dc.subject | Chronic obstructive pulmonary diseases |
dc.subject | Heat treatment |
dc.subject | Medical economics |
dc.title | A budget impact analysis of Spiromax compared with Turbuhaler for the treatment of moderate to severe asthma: a potential improvement in the inhalation technique to strengthen medication adherence could represent savings for the Spanish Healthcare System and five Spanish regions |
dc.type | info:eu-repo/semantics/article |
dc.type | info:eu-repo/semantics/publishedVersion |
dc.description.abstract |